Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1

SUMMARY Although both envelope glycoproteins of the hepatitis C virus, E1 and E2/NS1, show a high degree of sequence variation, the E1 protein includes a well conserved domain, which may be functionally important. We have analysed the human B cell response to a peptide fragment from amino acid resid...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental immunology Vol. 101; no. 2; pp. 278 - 283
Main Authors SIEMONEIT, K., CARDOSO, M. DA SILVA, KOERNER, K., WÖLPL, A., KUBANEK, B.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.1995
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:SUMMARY Although both envelope glycoproteins of the hepatitis C virus, E1 and E2/NS1, show a high degree of sequence variation, the E1 protein includes a well conserved domain, which may be functionally important. We have analysed the human B cell response to a peptide fragment from amino acid residues 314–330 (EP3) covering the central conserved sequence of this domain. Anti‐hepatitis C virus‐positive blood donors were screened for anti‐EP3 antibodies with an ELISA based on immobilized peptide. Thirty out of 92 (32%) RIBA‐confirmed donors displayed a significant antibody response to EP3. From three of these blood donors we established four anti‐EP3‐producing heterohybridoma cell lines: U1/F30 and U1/F31 produced IgM‐κ, whereas U1/F32 and U1/F33 secreted the isotypes IgG1‐λ and IgG1‐κ, respectively. Epitope analysis with overlapping nonapeptides suggests the existence of different antigenic determinants within the EP3 fragment. Although both IgG antibodies U1/F32 and U1/F33 have dissociation constants to the peptide of ∼ 10−9 M, binding to recombinant E1 protein expressed in COS‐7 cells was different. Only U1/F33 detected envelope protein of ∼ 24–35 kD in Western blot. This human MoAb will be useful for further investigations on the hepatitis C virus glycoprotein E1.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0009-9104
1365-2249
DOI:10.1111/j.1365-2249.1995.tb08351.x